Fig. 2From: Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumoursInterview by study nurse: Impact on everyday life and coping with the disease in patients on somatostatin analogue treatment for metastatic disease from small-intestinal neuroendocrine tumour at baseline and at 1-year follow-upBack to article page